1. Home
  2. CADL vs MLAB Comparison

CADL vs MLAB Comparison

Compare CADL & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$9.92

Market Cap

739.2M

Sector

Health Care

ML Signal

N/A

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

N/A

Current Price

$127.88

Market Cap

719.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
MLAB
Founded
1999
1982
Country
United States
United States
Employees
55
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
739.2M
719.9M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
CADL
MLAB
Price
$9.92
$127.88
Analyst Decision
Strong Buy
Buy
Analyst Count
9
3
Target Price
$21.75
★ $117.50
AVG Volume (30 Days)
★ 1.1M
96.3K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
★ 0.51%
EPS Growth
58.62
★ 436.11
EPS
N/A
★ 0.49
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$6.45
P/E Ratio
★ N/A
$257.27
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$66.56
52 Week High
$14.00
$144.35

Technical Indicators

Market Signals
Indicator
CADL
MLAB
Relative Strength Index (RSI) 36.74 50.16
Support Level $9.18 $91.42
Resistance Level $10.59 $132.70
Average True Range (ATR) 0.56 5.39
MACD -0.12 -1.11
Stochastic Oscillator 15.26 18.63

Price Performance

Historical Comparison
CADL
MLAB

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: